Robeco Institutional Asset Management B.V. increased its position in Stryker Corporation (NYSE:SYK) by 10.4% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 109,515 shares of the medical technology company’s stock after purchasing an additional 10,272 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Stryker Corporation were worth $15,199,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bollard Group LLC lifted its stake in shares of Stryker Corporation by 0.4% in the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock valued at $115,000 after purchasing an additional 3 shares during the period. James Investment Research Inc. bought a new position in Stryker Corporation during the 2nd quarter valued at approximately $155,000. Guardian Life Insurance Co. of America increased its position in Stryker Corporation by 0.8% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock valued at $158,000 after buying an additional 9 shares in the last quarter. Assetmark Inc. increased its position in Stryker Corporation by 0.3% during the 1st quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock valued at $168,000 after buying an additional 4 shares in the last quarter. Finally, Mosaic Family Wealth LLC increased its position in Stryker Corporation by 3.5% during the 1st quarter. Mosaic Family Wealth LLC now owns 1,300 shares of the medical technology company’s stock valued at $171,000 after buying an additional 44 shares in the last quarter. Institutional investors own 74.13% of the company’s stock.

In related news, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction on Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total value of $164,396.24. Following the transaction, the insider now owns 8,983 shares in the company, valued at $1,313,853.58. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares in the company, valued at approximately $12,909,976.52. The disclosure for this sale can be found here. Insiders have sold a total of 25,429 shares of company stock worth $3,686,927 in the last quarter. Company insiders own 7.40% of the company’s stock.

SYK has been the subject of a number of analyst reports. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $148.00 price objective on shares of Stryker Corporation in a research report on Thursday, August 24th. Needham & Company LLC raised Stryker Corporation from an “underperform” rating to a “hold” rating in a research report on Friday, August 25th. Cantor Fitzgerald initiated coverage on Stryker Corporation in a research report on Thursday, June 29th. They set a “neutral” rating and a $153.00 price objective for the company. Morgan Stanley reaffirmed an “overweight” rating and set a $160.00 price objective (up previously from $155.00) on shares of Stryker Corporation in a research report on Monday, July 10th. Finally, Zacks Investment Research raised Stryker Corporation from a “hold” rating to a “buy” rating and set a $163.00 price objective for the company in a research report on Monday, July 17th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the company. Stryker Corporation has a consensus rating of “Hold” and an average target price of $145.73.

TRADEMARK VIOLATION NOTICE: This piece was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/stryker-corporation-syk-shares-bought-by-robeco-institutional-asset-management-b-v/1581858.html.

Stryker Corporation (SYK) opened at 140.89 on Friday. The stock has a market capitalization of $52.70 billion, a P/E ratio of 31.45 and a beta of 0.81. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $148.84. The company’s 50-day moving average price is $143.56 and its 200 day moving average price is $138.98.

Stryker Corporation (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, topping the consensus estimate of $1.51 by $0.02. The firm had revenue of $3.01 billion for the quarter, compared to analysts’ expectations of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the business earned $1.39 EPS. On average, equities research analysts predict that Stryker Corporation will post $6.46 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be given a dividend of $0.425 per share. This represents a $1.70 annualized dividend and a yield of 1.21%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).

Institutional Ownership by Quarter for Stryker Corporation (NYSE:SYK)

Receive News & Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.